April 23, 2024
Bio
Korea United Pharm commences smart plant
[THE INVESTOR] Korea United Pharm said on March 24 it has started operations at its smart plant that will quadruple the drug maker’s production capability.
The fully automated factory, which integrates all drug manufacturing process, including packaging, is expected to cut production time by two to three times and reduce labor costs, Kang Duk-young, president of the firm said.
The fully automated factory, which integrates all drug manufacturing process, including packaging, is expected to cut production time by two to three times and reduce labor costs, Kang Duk-young, president of the firm said.
 |
“With the new production line, we will expand the production proportion of new modified drugs and seek to win orders for pharmaceutical plants from other drug makers,” Kang said.
Korea United Pharm developed the facility without external support.
The plant is equipped with vacuum transfer devices which minimize contamination and dust that can occur during the conventional manual material transfer process.
Through the smart factory, Korea United Pharm will manufacture its rheumatoid arthritis treatment Clanza, atherothrombosis therapy Clavixin and Cilostan, treatment of ischemic symptoms.
By Park Han-na (hnpark@heraldcorp.com)
![[Exclusive] Korean military set to ban iPhones over 'security' concerns](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2024/04/23/20240423050599_0.jpg)
![[Herald Interview] Bridging Korea, Philippines for better future](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2024/04/23/20240423050735_0.jpg)
